Long-term follow-up and disease monitoring in a NRAS mutated case of Ras-associated autoimmune leukoproliferative disorder onlinelibrary.wiley.com/doi/10.1111/bj… #leusm Enrico Attardi

We are young, we ❤️ hematology, transplant and cellular therapy! The EBMT Trainee Committee at #ASH23 ASH

Bravissimo Enrico Attardi presenting data on sAML and the intertwine on new and old diagnostic classifications at #ASH23

CONGRESS | #ASH23 Enrico Attardi Enrico Attardi Università di Roma Tor Vergata St. Jude dissects ICC “diagnostic qualifiers”, using a cohort of 155 patients with #AML progressing from #MDS or MDS/MPN (sAML) and 65 patients with tAML, and comparing to 233 patients with de novo MDS-related AML

Call for abstracts📣📣📣 APL symposium in Rome, Italy🇮🇹 deadline is January 17th European Hematology Association YoungEHA The EBMT ASH Young LABMT ASCO amazing opportunity to present your data and enjoy Rome!

The family of Clonal Hematopoiesis grows🌱: take a look at our review about CHIPI (clonal hematopoiesis in predisposed individuals), now In Press in Seminars in Hematology Marcin Wlodarski sciencedirect.com/science/articl…

Exploring the intricate dance between #CH and autoimmunity. Our latest review article with Robert Corty & Valeria Visconte shedding light on the complex interplay of genetics and inflammation. #CHIP #VEXAS #Autoimmunity Clonal hematopoiesis and autoimmunity sciencedirect.com/science/articl…

Marcin Wlodarski offers a brilliant overview of GATA2 and SAMD9/L syndromes at the Kyoto MDSR 2024🇯🇵 meeting MDS Foundation

Fueled by more recent research helping identify and treat Diamond Blackfan anemia syndrome, @MarrowGenes and collaborators helmed a multinational effort to create new DBA guidelines for treatment. The Lancet Haematology thelancet.com/journals/lanha…

Thanks Blood Cancer Discovery for the opportunity to write a “In the Spotlight” and congratulations to Caner Saygin, MD and co-authors for the beautiful paper! Check it out to know more about the role of “myeloid” mutations and clonal hematopoiesis in adult ALL aacrjournals.org/bloodcancerdis…

Malignant progression of preleukemic disorders ow.ly/mcbU50S48uy #myeloidneoplasia

I am proud to present my lab’s first research paper, published online in Leukemia Journal today! Check it out rdcu.be/dL6vp Congrats to first author Emily Stepanchick!

🎙️ New podcast out! Join Prof Maria Teresa Voso for insights on #MDS diagnosis & management. Hear about latest advancements in #PrecisionMedicine for MDS and the importance of personalized approaches in improving patient outcomes. Find it on #EHACampus: ehaedu.org/unplugged_PMin…

Exploring the erythroid world in LR-MDS! Congrats MDS-unit ! 👏👏👏 #MDSsm

Our "Germline Predisposition to MDS and AML" chapter is finally published in Springer's Book "Acute Myeloid Leukemia in Children." It was a pleasure co-authoring this chapter! rdcu.be/dROwb St. Jude

Announcement!!! 📣📣📣 We are looking for contributions for a Research Topic on de novo and secondary AML in Frontiers you can read about the project here: frontiersin.org/research-topic… #AMLsm #MDSsm

#ASH24 | Ilaria Iacobucci of St. Jude discusses myeloid mutations in ALL and provides insight into their role in identifying those at risk of secondary malignancies. 🧬🩸 Click here to watch: 👉 ow.ly/R7Tv50UGHaB #ALLsm #Leusm #CaGenome #Leukemia #HemOnc ASH

Antiaging for Ph-like ALL: targeting senescence ashpublications.org/blood/article/… I really enjoyed writing this Commentary on targeting senescent stem cell–like subpopulations in preclinical models of Ph-like ALL by dual JAK/STAT and BCL-2 inhibition. Out today in @BloodJournal #leukemia

Check out our new review on secondary and therapy-related AML🩸 Out in @SeminarsinHematology Secondary and therapy-related acute myeloid leukemias: Overlapping fea... sciencedirect.com/science/articl… Enrico Attardi Maria Teresa Voso